Ardent Health, Inc. (ARDT)

From the record

Ardent Health, Inc.'s filings since 2018 show no warning events in the scan: no bankruptcy or receivership notice, no debt default notice, no exchange listing notice, no restatement warning, no auditor change, no material cyber incident and no late-report notice (its current reports).

From the record

Ardent Health, Inc.'s 4 filed years say what it did: revenue went from $5.1 billion in fiscal 2022 to $6.3 billion in fiscal 2025, up 7.2% a year; it rose in 3 of 3 years; it never fell from a peak; net income was positive in 4 of 4 of those years (its annual reports).

From the record

Over the 3 fiscal years to 2025-12-31, Ardent Health, Inc.'s diluted share count grew about 3.9% a year, and dividends and buybacks returned about 0% of its operating cash flow over 3 years (its filed statements). Its officers and directors filed 0 sales and 2 purchases of their own stock on the open market in the year to 2026-09-30, buying about $186 thousand (their Form 4 filings).

From the record

Return on equity: in the fiscal year ended 2025-12-31, Ardent Health, Inc. earned about 8 cents of profit for every dollar of shareholders' money. Leverage: it owed about 68 cents per dollar of assets, and net share issuance: its share count grew 6.6% over the year (the filed statements).

From the record

Ardent Health, Inc.'s standing among 22 graded names in its industry family: revenue of $6.3 billion in fiscal 2025 ranks in the top 25% by size; a net margin of 2.1% ranks in the bottom 30%; revenue growth of 7.2% a year over the last 3 filed years ranks in the bottom 34% (its annual reports).

From the record

Ardent Health, Inc.'s leadership, from its insiders' filings and its current reports: the chief executive on the record is Caspers, Dave (CEO and President, as filed), filing under that title since 2026-07-02, 4 months (bottom 3% of its family); most of the 16 officers and directors filing now have filed since the record of its people begins (2024-07-17), a floor of 2.3 years the record cannot see past, so that part is not read; 8 officer or director changes were reported on Form 8-K since 2023-11-13, against the 16 people in charge now (top 50%; fewer changes for each person reads higher) (the Form 4 record, its Form 8-K reports). Years count from a person's first filing in the SEC's data sets, which begin in 2006, so each is a floor.

From the record

Ardent Health, Inc.'s room to grow, from the newest filed statements (fiscal 2025): cash of $710 million against debt of $1.1 billion leaves -6.9% of its assets as net cash, top 26% of its family; cash from operations less capital spending is 7.4% of revenue (top 43%) (its annual report).

From the record

Ardent Health, Inc.'s growth drivers, from the filed years to fiscal 2025: revenue grew 7.2% a year over the last three filed years against 7.2% over all 4, speeding up (bottom 27% of its family); the newest year grew 6% (bottom 34%) (its annual reports). Ardent Health, Inc. tags no split of its revenue by line in the annual report on file, so growth by line cannot be read here; research and capital spending are on the trend.

From the record

Ardent Health, Inc.'s newest year against its own record: revenue of $6.3 billion in fiscal 2025 came in 1.7% below the $6.4 billion its prior three years' pace pointed to (bottom 34% of its family); net income of $136 million against a prior three-year average of $151 million (bottom 16%); a net margin of 2.1% against 2.7% before (bottom 30%) (its annual reports).